Ameliorative anti-diabetic activity of Dangnyosoko, a Chinese herbal medicine, in diabetic rats

34Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The preventive anti-diabetic effect of dangnyosoko (DNSK), a Chinese herbal medicine, was evaluated in STZ-induced diabetic rats. DNSK was orally administered once a day from 3d after STZ-induction at 100, 200, and 500mg/kg for 4 weeks, and the results were compared to those for glibenclamide. Dramatic decreases in body weight and plasma insulin levels and increases in blood and urine glucose levels were detected in STZ-induced diabetic animals with disruption and disappearance of pancreatic islets and increases in glucagon- and decreases in insulin-producing cells. However, these diabetic changes were significantly and dose-dependently inhibited by treatment with DNSK, and DNSK at 100 mg/kg showed more favorable effects than glibenclamide at 5 mg/kg. Based on these results, it is thought that DNSK has favorable effects in ameliorating changes in blood and urine glucose levels and body weight, and that histopathological changes in the pancreas in STZ induce diabetes.

Cite

CITATION STYLE

APA

Kim, J. D., Kang, S. M., Park, M. Y., Jung, T. Y., Choi, H. Y., & Ku, S. K. (2007). Ameliorative anti-diabetic activity of Dangnyosoko, a Chinese herbal medicine, in diabetic rats. Bioscience, Biotechnology and Biochemistry, 71(6), 1527–1534. https://doi.org/10.1271/bbb.70058

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free